demonstrated that HBV-related HCC was related to the dysregulation of insulin-IGF-1/IGFBP function and that the overexpression of IGF2 accelerated the formation of liver tumors with the hepatic expression of MYC and AKT1. The gene discussed is IGF2; the disease is hepatocellular carcinoma.